Kanel Indust. (500236)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• ROE is positive at 7.36%, albeit based on a likely tiny equity base.
• Latest quarterly loss is effectively ₹0 Cr, so cash burn appears limited.
• As a trading and distribution entity, it could generate cash with relatively low fixed capital if operations ever resume.

Concerns

• P/E of 0.00 and sales of ₹0 Cr leave no earnings to validate the ₹3 Cr market cap.
• Profit growth of -350% and Piotroski F-Score of 2/9 point to severe underlying deterioration.
• ROCE of -0.72% means operations are destroying value after capital costs.
• 52-week range (₹10.00–₹32.14) versus current ₹1.42 suggests a data anomaly or catastrophic price collapse; neither is reassuring.

AI Analysis

When I look at Kanel Indust., I am reminded of Mr. Market at his most manic. The price is ₹1.42, and the entire company is valued at just ₹3 Cr. That sounds tiny enough to be interesting, but the figures behind it are empty. P/E shows 0.00 because there are no earnings to speak of; latest quarter sales are ₹0 Cr and net profit is ₹-0 Cr. You cannot begin a Graham analysis without earnings and book value, and here both are missing or near-zero. Profit growth at -350% and Piotroski F-Score of 2/9 are flashing distress, not hidden value. A ROCE of -0.72% means the trading and distribution operations are not earning enough to cover the cost of capital. The supposed positive ROE of 7.36% gives me no comfort; with no meaningful equity base, that ratio can be a mirage. The 52-week range of ₹10.00 to ₹32.14 versus today's ₹1.42 is bizarre. Either the data need adjustment for splits or corporate actions, or this stock has suffered a catastrophic repricing. In either case, Buffett says avoid what you cannot understand. There is no moat, no pricing power, no sales growth, no dividend, and no promoter holding disclosure. A true value investor needs a margin of safety; here, the lack of data is large and the margin of safety is nonexistent. Kanel might become a turnaround someday, but only after real sales return and financial statements become trustworthy. Until then, I would rather miss the move than lose capital. Price is what you pay, value is what you get—and with no visible earnings, book value, or cash flows, I cannot even estimate the value. This is a pass.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer